Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP selling, general and administrative expenses by Quarter
Non-GAAP selling, general and administrative (SG&A) expenses ($M) ($M)
Gilead Sciences Non-GAAP selling, general and administrative expenses: $1,921M in Q2 2026, up 40.7% from a year earlier.
Where the Q2 2026 figure comes from
“|| Selling, general and administrative expenses | 1,921 | 1,365 | 3,372 | 2,623”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-GAAP selling, general and administrative expenses
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP selling, general and administrative expenses ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-sga
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.